Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      US Congressmen seek briefing on contaminated drugs from India, China

      US Congressmen seek briefing on contaminated drugs from India, China

      Medical Dialogues Bureau17 Feb 2019 9:00 AM IST
      The recalls appear to be connected to at least two foreign drugs manufacturing facilities -- Zhejiang Huahai Pharmaceutical in China and Hetero Labs...
      Supreme Court refuses interim order on sale of Fortis shares to IHH; final hearing on February 26

      Supreme Court refuses interim order on sale of Fortis shares to IHH; final hearing on February 26

      Medical Dialogues Bureau16 Feb 2019 12:33 PM IST
      A bench comprising Chief Justice Ranjan Gogoi and Justice Sanjiv Khanna said that it would accord final hearing in the case on February 26.New Delhi:...
      New cancer drugs help upbeat AstraZeneca beat forecasts

      New cancer drugs help upbeat AstraZeneca beat forecasts

      Medical Dialogues Bureau16 Feb 2019 9:05 AM IST
      AstraZeneca has suffered the industry's biggest loss of drug patents since 2012, wiping out more than half of its sales, but analysts now believe it...
      Irish drug trial technology firm Teckro wins $25 million injection

      Irish drug trial technology firm Teckro wins $25 million injection

      Medical Dialogues Bureau16 Feb 2019 9:00 AM IST
      It will allow Teckro to expand internationally and develop its machine-learning based digital platform, which it sells to drugmakers.Ireland:...
      Sanofi appoints Ameet Nathwani as Chief Digital Officer

      Sanofi appoints Ameet Nathwani as Chief Digital Officer

      Medical Dialogues Bureau14 Feb 2019 9:00 AM IST
      As Chief Digital Officer, Dr Ameet Nathwani will be responsible for enhancing Sanofi’s strategy to integrate digital technologies and medical science...
      J&J nasal spray esketamine wins FDA panel backing

      J&J nasal spray esketamine wins FDA panel backing

      Medical Dialogues Bureau13 Feb 2019 9:30 AM IST
      J&J’s esketamine, used in combination with a newly prescribed antidepressant, works by restoring the nerve cell connections in the brain, leading...
      Government, private sector need to work together for increasing healthcare affordability: Experts

      Government, private sector need to work together for increasing healthcare affordability: Experts

      Medical Dialogues Bureau13 Feb 2019 9:25 AM IST
      Healthcare equipment maker Vygon India MD Pavan Choudary said there is a need to focus on areas like transparency and alternative mechanism of price...
      Catalyst Pharma sees net price of drug, once free, topping $300,000

      Catalyst Pharma sees net price of drug, once free, topping $300,000

      Medical Dialogues Bureau12 Feb 2019 9:00 AM IST
      The Catalyst Pharma drug also received orphan drug status from the FDA, which comes with seven years of marketing exclusivity to encourage the...
      Glenmark Pharma gets USFDA nod for drug for patients on dialysis

      Glenmark Pharma gets USFDA nod for drug for patients on dialysis

      Medical Dialogues Bureau11 Feb 2019 3:48 PM IST
      New Delhi: Glenmark Pharmaceuticals Monday said it has received final approval from the US health regulator for Sevelamer Hydrochloride tablets, used...
      At least four pharma CEOs to testify at Senate drug pricing hearing

      At least four pharma CEOs to testify at Senate drug pricing hearing

      Medical Dialogues Bureau10 Feb 2019 9:00 AM IST
      Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee on...
      Health Horizons launches its range of Hemp Soaps

      Health Horizons launches its range of Hemp Soaps

      Medical Dialogues Bureau8 Feb 2019 9:00 AM IST
      Health Horizons are manufacturers and distributors of consumable and skincare products derived from the miracle plant - Hemp.NOIDA: Health Horizons,...
      Liver drug may slow Parkinson Disease progression

      Liver drug may slow Parkinson Disease progression

      Medical Dialogues Bureau7 Feb 2019 9:15 AM IST
      After screening 2,000 drugs, researchers from the University of Sheffield in the UK identified ursodeoxycholic acid (UDCA) as the most promising drug...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok